The ability of a pharmacologically relevant single target to control regeneration and survival in multiple tissues identifies PAR2 as a therapeutic target in those and possibly other disorders involving tissue damage and regeneration, including T1D. The gene discussed is F2RL1; the disease is type 1 diabetes mellitus.